| Nome |
# |
|
A rare case of IgM-Multiple Myeloma, file dd9e0c65-4183-1e9c-e053-3a05fe0a45ef
|
143
|
|
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapy, file dd9e0c6c-4934-1e9c-e053-3a05fe0a45ef
|
104
|
|
SETBP1 dysregulation in congenital disorders and myeloid neoplasms, file dd9e0c6a-e6cc-1e9c-e053-3a05fe0a45ef
|
103
|
|
Next-generation sequencing for sensitive detection of BCR-ABL1 mutations relevant to tyrosine kinase inhibitor choice in imatinib-resistant patients, file dd9e0c64-3f73-1e9c-e053-3a05fe0a45ef
|
100
|
|
Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart, file dd9e0c6a-cb93-1e9c-e053-3a05fe0a45ef
|
85
|
|
Design and MinION testing of a nanopore targeted gene sequencing panel for chronic lymphocytic leukemia, file dd9e0c65-6fb8-1e9c-e053-3a05fe0a45ef
|
81
|
|
Differences among young adults, adults, and elderly chronic myeloid
leukemia patients., file dd9e0c65-3e12-1e9c-e053-3a05fe0a45ef
|
69
|
|
The JAK2 GGCC (46/1) haplotype in myeloproliferative neoplasms: Causal or random?, file dd9e0c65-4002-1e9c-e053-3a05fe0a45ef
|
65
|
|
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia, file dd9e0c6b-1319-1e9c-e053-3a05fe0a45ef
|
64
|
|
Impact of induction regimen and allogeneic hematopoietic cell transplantation on outcome in younger adults with acute myeloid leukemia with a monosomal karyotype, file dd9e0c65-a13a-1e9c-e053-3a05fe0a45ef
|
60
|
|
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients, file dd9e0c6b-1e75-1e9c-e053-3a05fe0a45ef
|
58
|
|
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia, file dd9e0c6a-f177-1e9c-e053-3a05fe0a45ef
|
56
|
|
Droplet Digital PCR Is a Robust Tool for Monitoring Minimal Residual Disease in Adult Philadelphia-Positive Acute Lymphoblastic Leukemia, file dd9e0c6c-84a6-1e9c-e053-3a05fe0a45ef
|
56
|
|
Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies, file dd9e0c67-37be-1e9c-e053-3a05fe0a45ef
|
55
|
|
Absolute quantification of the pretreatment PML-RARA transcript defines the relapse risk in acute promyelocytic leukemia., file dd9e0c63-9fe0-1e9c-e053-3a05fe0a45ef
|
53
|
|
MYEOV gene overexpression in primary plasma cell leukemia with t(11;14)(q13;q32), file dd9e0c64-3f70-1e9c-e053-3a05fe0a45ef
|
53
|
|
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib, file dd9e0c6a-f391-1e9c-e053-3a05fe0a45ef
|
53
|
|
TP53 gene mutation analysis in chronic lymphocytic leukemia by nanopore MinION sequencing, file dd9e0c63-9976-1e9c-e053-3a05fe0a45ef
|
52
|
|
STAT-3 RNAscope Determination in Human Diffuse Large B-Cell Lymphoma, file dd9e0c65-a27e-1e9c-e053-3a05fe0a45ef
|
52
|
|
Monosomal karyotype in myeloid neoplasias: a literature review, file dd9e0c64-0ffb-1e9c-e053-3a05fe0a45ef
|
51
|
|
Rotation of nilotinib and imatinib for first-line treatment of chronic phase chronic myeloid leukemia, file dd9e0c64-3f75-1e9c-e053-3a05fe0a45ef
|
51
|
|
Droplet digital PCR analysis of NOTCH1 gene mutations in chronic lymphocytic leukemia, file dd9e0c64-4159-1e9c-e053-3a05fe0a45ef
|
49
|
|
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis, file dd9e0c65-3d7b-1e9c-e053-3a05fe0a45ef
|
49
|
|
Stat3-positive tumor cells contribute to vessels neoformation in primary central nervous system lymphoma, file dd9e0c64-1519-1e9c-e053-3a05fe0a45ef
|
48
|
|
Impact of bone marrow aspirate tregs on the response rate of younger newly diagnosed acute myeloid leukemia patients, file dd9e0c65-7308-1e9c-e053-3a05fe0a45ef
|
47
|
|
Genomic BCR-ABL1 breakpoint characterization by a multistrategy approach for "personalized monitoring" of residual disease in chronic myeloid leukemia patients, file dd9e0c65-2b94-1e9c-e053-3a05fe0a45ef
|
46
|
|
Managing Chronic Myeloid Leukemia for Treatment-Free Remission: A Proposal From the GIMEMA CML WP, file dd9e0c67-1a11-1e9c-e053-3a05fe0a45ef
|
46
|
|
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial, file dd9e0c65-4239-1e9c-e053-3a05fe0a45ef
|
45
|
|
Skin lesions in chronic myeloid leukemia patients during dasatinib treatment, file dd9e0c67-37c1-1e9c-e053-3a05fe0a45ef
|
44
|
|
Development and evaluation of a secondary reference panel for BCR-ABL1 quantification on the International Scale, file dd9e0c63-9fe3-1e9c-e053-3a05fe0a45ef
|
39
|
|
Next-Generation Sequencing in Acute Lymphoblastic Leukemia, file dd9e0c65-b56a-1e9c-e053-3a05fe0a45ef
|
35
|
|
Validation and reference values of the EORTC QLQ-CML24 questionnaire to assess health-related quality of life in patients with chronic myeloid leukemia, file dd9e0c6c-06af-1e9c-e053-3a05fe0a45ef
|
33
|
|
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis, file dd9e0c6c-21b6-1e9c-e053-3a05fe0a45ef
|
32
|
|
Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia, file dd9e0c6a-2bbb-1e9c-e053-3a05fe0a45ef
|
30
|
|
Incidence of second primary malignancies and related mortality in patients with imatinib-treated chronic myeloid leukemia, file dd9e0c65-4007-1e9c-e053-3a05fe0a45ef
|
29
|
|
Driver mutations' effect in secondary myelofibrosis: An international multicenter study based on 781 patients, file dd9e0c6a-0fe5-1e9c-e053-3a05fe0a45ef
|
28
|
|
FLT3 mutational analysis in acute myeloid leukemia: Advantages and pitfalls with different approaches, file dd9e0c6b-f1b9-1e9c-e053-3a05fe0a45ef
|
25
|
|
The BCR-ABL1 transcript type influences response and outcome in Philadelphia chromosome-positive chronic myeloid leukemia patients treated frontline with imatinib, file dd9e0c64-4273-1e9c-e053-3a05fe0a45ef
|
24
|
|
Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme, file dd9e0c64-566c-1e9c-e053-3a05fe0a45ef
|
18
|
|
Droplet digital PCR assay for quantifying of CALR mutant allelic burden in myeloproliferative neoplasms, file dd9e0c6a-15fa-1e9c-e053-3a05fe0a45ef
|
18
|
|
SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance, file df13bdc0-fa56-4e29-8390-f0edeaa333ea
|
14
|
|
What Is New in the Treatment of Smoldering Multiple Myeloma?, file dd9e0c6b-52f5-1e9c-e053-3a05fe0a45ef
|
12
|
|
BCL6 corepressor gene dysregulation due to chromosomal translocation in acute myeloid leukemia: a new mechanism based on long non-coding RNA dislocation?, file dd9e0c64-6234-1e9c-e053-3a05fe0a45ef
|
11
|
|
A novel t(3;9)(q21.2; p24.3) associated with SMARCA2 and ZNF148 genes rearrangement in myelodysplastic syndrome, file dd9e0c6a-0344-1e9c-e053-3a05fe0a45ef
|
11
|
|
Fatigue in newly diagnosed acute myeloid leukaemia: General population comparison and predictive factors, file dd9e0c6b-d8f2-1e9c-e053-3a05fe0a45ef
|
11
|
|
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib, file dd9e0c6c-433d-1e9c-e053-3a05fe0a45ef
|
11
|
|
Genome characterization and CRISPR-Cas9 editing of a human neocentromere, file ad623b95-20c9-4ec9-b582-e1146be873fb
|
10
|
|
SETBP1 and miR_4319 dysregulation in primary myelofibrosis progression to acute
myeloid leukemia., file dd9e0c62-f9a3-1e9c-e053-3a05fe0a45ef
|
9
|
|
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto, file dd9e0c63-998f-1e9c-e053-3a05fe0a45ef
|
8
|
|
Ruxolitinib – better prognostic impact in low-intermediate 1 risk score: evaluation of the ‘rete ematologica pugliese’ (REP) in primary and secondary myelofibrosis, file dd9e0c6a-0fde-1e9c-e053-3a05fe0a45ef
|
8
|
|
IgG-lymphoplasmacytic lymphoma following polycythemia vera: JAK2 V617F and MYD88 L265P mutations separated in the same house., file dd9e0c64-61fd-1e9c-e053-3a05fe0a45ef
|
7
|
|
Impact of BCR-ABL mutations on response to dasatinib after imatinib failure in elderly patients with chronic-phase chronic myeloid leukemia, file dd9e0c64-6f43-1e9c-e053-3a05fe0a45ef
|
7
|
|
Analysis of percent identity of IGHV mutation as prognostic factor in CLL patients treated with fludarabine, cyclofosfamide and rituximab: a single centre experience, file dd9e0c65-4981-1e9c-e053-3a05fe0a45ef
|
6
|
|
Erythrocytosis with JAK2 GGCC_46/1 haplotype and without JAK2 V617F mutation is associated with CALR rs1049481_G allele, file dd9e0c6b-beea-1e9c-e053-3a05fe0a45ef
|
6
|
|
Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia, file dd9e0c63-9991-1e9c-e053-3a05fe0a45ef
|
5
|
|
Outcome of allogeneic peripheral blood stem cell transplantation by donor graft CD3+/Tregs ratio: a single-center experience., file dd9e0c64-6b86-1e9c-e053-3a05fe0a45ef
|
5
|
|
Centromeric fragment of chromosome 7 in atypical chronic myeloid leukemia with
the SET binding protein 1 gene mutation., file dd9e0c67-1588-1e9c-e053-3a05fe0a45ef
|
5
|
|
RARG Gene Dysregulation in Acute Myeloid Leukemia, file dd9e0c69-b6ca-1e9c-e053-3a05fe0a45ef
|
5
|
|
Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996, file dd9e0c6b-dc0d-1e9c-e053-3a05fe0a45ef
|
5
|
|
Gene expression profiling of chronic myeloid leukemia with variant t(9;22) reveals a different signature from cases with classic translocation., file dd9e0c63-9adf-1e9c-e053-3a05fe0a45ef
|
4
|
|
ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia., file dd9e0c64-5d94-1e9c-e053-3a05fe0a45ef
|
4
|
|
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project, file dd9e0c69-f7bb-1e9c-e053-3a05fe0a45ef
|
4
|
|
Dysregulation of mirna in leukemia: Exploiting mirna expression profiles as biomarkers, file dd9e0c6b-5df6-1e9c-e053-3a05fe0a45ef
|
4
|
|
Favorable outcome of chronic myeloid leukemia co-expressing e13a2 and e14a2 transcripts, treated with nilotinib, file dd9e0c6b-fdc8-1e9c-e053-3a05fe0a45ef
|
4
|
|
Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study, file 6c502674-a02c-4353-a095-cdee57fe1529
|
3
|
|
null, file dd9e0c62-fba4-1e9c-e053-3a05fe0a45ef
|
3
|
|
Lymphoid Enhancer Binding Factor-1 (LEF1) expression as
a prognostic factor in adult acute promyelocytic leukemia., file dd9e0c63-9ae2-1e9c-e053-3a05fe0a45ef
|
3
|
|
Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib, file dd9e0c63-a047-1e9c-e053-3a05fe0a45ef
|
3
|
|
Myelodysplastic syndrome with 5q deletion following IgM monoclonal gammopathy,
showing gene mutation MYD88 L265P., file dd9e0c64-55c3-1e9c-e053-3a05fe0a45ef
|
3
|
|
5'RUNX1-3'USP42 chimeric
gene in acute myeloid leukemia can occur through an insertion mechanism rather
than translocation and may be mediated by genomic segmental duplications., file dd9e0c64-5bec-1e9c-e053-3a05fe0a45ef
|
3
|
|
Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile., file dd9e0c64-6606-1e9c-e053-3a05fe0a45ef
|
3
|
|
Outcome of 82 chronic myeloid leukemia patients treated with nilotinib or dasatinib after failure of two prior tyrosine kinase inhibitors., file dd9e0c64-69b1-1e9c-e053-3a05fe0a45ef
|
3
|
|
The Pleiotropic Role of Retinoic Acid/Retinoic Acid Receptors Signaling: From Vitamin A Metabolism to Gene Rearrangements in Acute Promyelocytic Leukemia, file dd9e0c65-bb7c-1e9c-e053-3a05fe0a45ef
|
3
|
|
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO), file dd9e0c67-2057-1e9c-e053-3a05fe0a45ef
|
3
|
|
null, file dd9e0c67-49c8-1e9c-e053-3a05fe0a45ef
|
3
|
|
Nanopore targeted sequencing for rapid gene mutations detection in acute myeloid leukemia, file dd9e0c69-b5e4-1e9c-e053-3a05fe0a45ef
|
3
|
|
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project, file dd9e0c6a-2bb8-1e9c-e053-3a05fe0a45ef
|
3
|
|
Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention, file dd9e0c6b-0d1d-1e9c-e053-3a05fe0a45ef
|
3
|
|
Hypereosinophilia with a pinch of salt and pepper, file dd9e0c6b-4425-1e9c-e053-3a05fe0a45ef
|
3
|
|
PB2064 USE OF RNASCOPE TECHNOLOGY TO DETERMINE STAT-3 EXPRESSION IN HUMAN DIFFUSE LARGE B-CELL LYMPHOMA, file dd9e0c6b-6855-1e9c-e053-3a05fe0a45ef
|
3
|
|
Immunomodulatory drugs in acute myeloid leukemia treatment, file dd9e0c6b-92b6-1e9c-e053-3a05fe0a45ef
|
3
|
|
Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick, file dd9e0c6b-dc10-1e9c-e053-3a05fe0a45ef
|
3
|
|
Concomitant tetrasomy 3q and trisomy 18 in CD5- CD13+ chronic lymphocytic leukemia, file dd9e0c62-46f1-1e9c-e053-3a05fe0a45ef
|
2
|
|
Droplet Digital PCR Is a Reliable Tool for Monitoring Minimal Residual Disease in Acute Promyelocytic Leukemia, file dd9e0c64-3190-1e9c-e053-3a05fe0a45ef
|
2
|
|
Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3, file dd9e0c64-5be8-1e9c-e053-3a05fe0a45ef
|
2
|
|
A novel t(4;16)(q25;q23.1) associated with EGF and ELOVL6 deregulation in acute myeloid leukemia, file dd9e0c64-6403-1e9c-e053-3a05fe0a45ef
|
2
|
|
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis, file dd9e0c65-4233-1e9c-e053-3a05fe0a45ef
|
2
|
|
t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene, file dd9e0c66-1a8f-1e9c-e053-3a05fe0a45ef
|
2
|
|
Non-treatment-related chronic myeloid leukemia as a second malignancy, file dd9e0c67-437f-1e9c-e053-3a05fe0a45ef
|
2
|
|
Inflammatory Infiltrate and Angiogenesis in Mantle Cell Lymphoma, file dd9e0c67-9765-1e9c-e053-3a05fe0a45ef
|
2
|
|
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study, file dd9e0c68-27d2-1e9c-e053-3a05fe0a45ef
|
2
|
|
Molecular complexity of diffuse large B-cell lymphoma: Can it be a roadmap for precision medicine?, file dd9e0c68-4116-1e9c-e053-3a05fe0a45ef
|
2
|
|
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group, file dd9e0c68-4119-1e9c-e053-3a05fe0a45ef
|
2
|
|
Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities, file dd9e0c68-4263-1e9c-e053-3a05fe0a45ef
|
2
|
|
Superiority of droplet digital PCR over real-time quantitative PCR for JAK2 V617F allele mutational burden assessment in myeloproliferative neoplasms: A retrospective study, file dd9e0c68-7085-1e9c-e053-3a05fe0a45ef
|
2
|
|
Monitoring of minimal residual disease (Mrd) in chronic myeloid leukemia: Recent advances, file dd9e0c68-7099-1e9c-e053-3a05fe0a45ef
|
2
|
|
HMGA proteins in hematological malignancies, file dd9e0c68-78fb-1e9c-e053-3a05fe0a45ef
|
2
|
|
TP53 in myelodysplastic syndromes: Recent biological and clinical findings, file dd9e0c68-8d65-1e9c-e053-3a05fe0a45ef
|
2
|
|
Digital pcr: A reliable tool for analyzing and monitoring hematologic malignancies, file dd9e0c68-8d66-1e9c-e053-3a05fe0a45ef
|
2
|
|
Epitranscriptomics in normal and malignant hematopoiesis, file dd9e0c69-36fd-1e9c-e053-3a05fe0a45ef
|
2
|
| Totale |
2.415 |